9877 — Jenscare Scientific Co Income Statement
0.000.00%
Last trade - 00:00- HK$1.72bn
- HK$886.97m
- 17
- 16
- 64
- 20
Annual income statement for Jenscare Scientific Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 299 | 502 | 457 | 398 |
| Operating Profit | -299 | -502 | -457 | -398 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -300 | -501 | -441 | -379 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -300 | -501 | -441 | -379 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -299 | -501 | -439 | -372 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -299 | -501 | -439 | -372 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.718 | -1.2 | -1.2 | -0.885 |